Imitrex vs. Emgality

See how Imitrex and Emgality compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Imitrex is taken at the first sign of a migraine to stop an attack already underway, while Emgality is injected monthly to prevent migraines before they start.

  • Imitrex can relieve pain within about an hour, but Emgality's preventive benefit builds gradually over the first few months of treatment.

  • Imitrex has cardiovascular contraindications that rule it out for some patients, while Emgality carries no boxed warning but can worsen Raynaud's phenomenon.

Imitrex vs. Emgality Drug Summary

Imitrex

Imitrex is a triptan (5-HT1B/1D receptor agonist) used for the acute treatment of migraine attacks and cluster headaches. It's taken as a tablet at the first sign of a migraine, with a second dose allowed after two hours if needed. It only stops a migraine already underway; it isn't used to prevent them.

Emgality

Emgality is a CGRP-antagonist monoclonal antibody used to prevent migraines and episodic cluster headaches before they start. It's given as a once-monthly self-injection, starting with a double loading dose in month one. It doesn't treat a migraine that has already begun.

Imitrex vs. Emgality Side Effects

Imitrex

Most common
pain/pressure sensations (up to 8%)
paresthesia (up to 6%)
warm/cold sensation (up to 3%)
malaise/fatigue (up to 3%)

Emgality

Most common
injection site reactions (up to 18%)
injection site pain (up to 11.6%)
constipation (up to 1.5%)
vertigo (up to 1.2%)

Imitrex vs. Emgality Dosage

Imitrex

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 25 mg, 50 mg, or 100 mg At the start
Maximum dose Repeat dose, max 200mg/day If needed
Dose changes 1 increase As tolerated

Emgality

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 240 mg Day 1
Maximum dose 300 mg once monthly If needed
Dose changes 2 increases As tolerated

Imitrex vs. Emgality Indications

Imitrex

Imitrex is FDA-approved for the acute treatment of migraine, with or without aura, in adults. It's also approved as an injection for acute cluster headache attacks. It is meant to stop a migraine that has already started, not to prevent future ones.

  • Acute treatment of migraine attacks, with or without aura, in adults

  • Acute treatment of cluster headache (injection form only)

  • Used to stop a migraine already in progress, not to prevent one

  • Available as tablet, nasal spray, or injection for different speeds of relief

Emgality

Emgality is FDA-approved for the preventive treatment of migraine in adults, reducing how often attacks occur. It's also approved to treat episodic cluster headache. It is not used to treat a migraine once it has already started.

  • Preventive treatment to reduce migraine frequency in adults

  • Treatment of episodic cluster headache in adults

  • Given monthly to head off attacks before they begin

  • Not used for treating a migraine that has already started

Imitrex vs. Emgality Pros and Cons

Imitrex

Imitrex has a long track record for stopping migraine pain quickly, backed by decades of real-world use. Its cardiovascular contraindications mean it isn't suitable for people with heart disease, uncontrolled blood pressure, or a history of stroke.

Pros

  • Works fast, often within an hour, for a migraine already underway

  • Available in tablet, nasal spray, and injection forms for flexible dosing

  • Decades of real-world use with well-established safety data

  • Can be redosed the same day if migraine symptoms return

Cons

  • Not approved for migraine prevention, only for acute attacks

  • Contraindicated in people with heart disease, stroke history, or uncontrolled high blood pressure

  • Cannot be combined with another triptan or ergot medicine within 24 hours

  • Carries a risk of serotonin syndrome when combined with SSRIs or SNRIs

Emgality

Emgality is built for prevention, cutting down how many migraines happen each month rather than treating one already in progress. Its main tradeoff is that it offers no benefit for an attack that's already underway, and injection site reactions are common.

Pros

  • Designed specifically to prevent migraines, reducing how often they occur

  • Only needs to be injected once a month

  • No boxed warning and no cardiovascular contraindications like triptans

  • Also approved to prevent episodic cluster headache attacks

Cons

  • Does not treat a migraine once it has already started

  • Can cause new or worsening Raynaud's phenomenon

  • Requires an initial double-dose injection to build up levels

  • Injection site reactions are common, affecting up to 18% of users

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.